E Komlodi-Pasztor, DL Sackett, AT Fojo - Clinical Cancer Research, 2012 - AACR
Although they have been advocated with an understandable enthusiasm, mitosis-specific
agents such as inhibitors of mitotic kinases and kinesin spindle protein have not been …